Our journey started from the dreaming spires of Oxford. We came together around a shared belief: better care begins with better evidence and that modern diagnostics should unite reproducible biological measurement with advanced computation.
Oxford Cancer Analytics brings together a multidisciplinary team spanning clinical medicine, proteomics, machine learning, and business. United by scientific rigour and a shared commitment to clinical impact, we are developing a minimally invasive diagnostic approach powered by high-throughput measurement of the circulating proteome and modern AI. Our platform generates evidence-based insights designed to support clinical decision-making in lung disease, starting with Chronic Obstructive Pulmonary Disease (COPD), with broader applicability including lung cancer.
%20(1).svg)